公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Potent cell-cycle inhibition and upregulation of immune response with abemaciclib and anastrozole in Neomonarch, phase II neoadjuvant study in HR+/HER2- Breast cancer | Hurvitz S.A.; Martin M.; Press M.F.; Chan D.; Fernandez-Abad M.; Petru E.; Rostorfer R.; Guarneri V.; CHIUN-SHENG HUANG ; Barriga S.; Wijayawardana S.; Brahmachary M.; Ebert P.J.; Hossain A.; Liu J.; Abel A.; Aggarwal A.; Jansen V.M.; Slamon D.J. | Clinical Cancer Research | 126 | 111 |